论文部分内容阅读
急性白血病是常见的一种造血系统恶性肿瘤,在我国有逐年增加的趋势。据统计,发病率约为3—4人/每10万人口。本病来势凶猛、病情险恶、进展迅速,如不及时治疗,病员往往于短期内死亡。急性白血病的治疗是一件非常细致而复杂的工作。对本病的治疗,已从过去束手无策进入能获得良好缓解的阶段。近十多年来,联合化疗的设计,使本病的存活期显著延长,急性淋巴细胞性白血病(下简称“急淋”)尤然,存活超过5年的屡见不鲜。国内在采用中西医结合治疗白血病以来,在诱导缓解、渡过骨髓抑制衰竭期、促进血细胞的增殖和恢复诸方面,取得了良好的成绩,使
Acute leukemia is a common type of hematopoietic malignancy that has been increasing year by year in China. According to statistics, the incidence rate is about 3-4 people per 100,000 population. The disease is ferocious, the condition is sinister, and the progress is rapid. If it is not treated in time, the patients often die in a short period of time. The treatment of acute leukemia is a very detailed and complicated work. The treatment of the disease has gone from the past to the stage of good remission. In the past decade, the design of combined chemotherapy has significantly extended the survival period of this disease, especially acute lymphoblastic leukemia (hereinafter referred to as “emergency leukemia”), and has survived for more than 5 years. After adopting Chinese and Western medicine in the treatment of leukemia in China, we have achieved good results in induction of remission, the failure of myelosuppression failure, and the promotion of proliferation and recovery of blood cells.